Literature DB >> 27751827

Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats.

Juan Bai1, Ying Zhu2, Ying Dong3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Bitter melon (Momordica charantia L.) is rich in a variety of biologically active ingredients, and has been widely used in traditional Chinese medicine (TCM) to treat various diseases, including type 2 diabetes and obesity. AIM OF THE STUDY: We aimed to investigate how bitter melon powder (BMP) could affect obesity-associated inflammatory responses to ameliorate high-fat diet (HFD)-induced insulin resistance, and investigated whether its anti-inflammatory properties were effected by modulating the gut microbiota.
MATERIALS AND METHODS: Obese SD rats (Sprague-Dawley rats, rattus norregicus) were randomly divided into four groups: (a) normal control diet (NCD) and distilled water, (b) HFD and distilled water, (c) HFD and 300mg BMP/kg body weight (bw), (d) HFD and 10mg pioglitazone (PGT)/kg bw.
RESULTS: We observed remarkable decreases in the fasting glucose, fasting insulin, HOMA-IR index, serum lipid levels, and cell sizes of epididymal adipose tissues in the BMP and PGT groups after 8 weeks. BMP could significantly improve the proinflammatory cytokine tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), anti-inflammatory cytokine interleukin-10 (IL-10), and local endotoxin levels compared to the HFD group (p<0.05). BMP suppressed the activation of nuclear factor-κB (NF-κB) by inhibiting inhibitor of NF-κB alpha (IκBα) degradation and phosphorylation of c-Jun N-terminal kinase/ p38 mitogen-activated protein kinases (JNK/p38 MAPKs) in adipose tissue. Sequencing results illustrated that BMP treatment markedly decreased the proportion of the endotoxin-producing opportunistic pathogens and increased butyrate producers.
CONCLUSIONS: These results demonstrate that BMP ameliorates insulin sensitivity partly via relieving the inflammatory status in the system and in white adipose tissues of obese rats, and is associated with a proportional regulation of specific gut microbiota.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bitter melon; Gut microbiota; Inflammation; Insulin resistance; Obesity

Mesh:

Substances:

Year:  2016        PMID: 27751827     DOI: 10.1016/j.jep.2016.10.043

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  19 in total

Review 1.  Role and effective therapeutic target of gut microbiota in NAFLD/NASH.

Authors:  Qun Liu; Shousheng Liu; Lizhen Chen; Zhenzhen Zhao; Shuixian Du; Quanjiang Dong; Yongning Xin; Shiying Xuan
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

2.  [Approach to creating early diabetic peripheral neuropathy rat model].

Authors:  J He; G H Yuan; J Q Zhang; X H Guo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

3.  Obese rats supplemented with bitter melon display marked shifts in the expression of genes controlling inflammatory response and lipid metabolism by RNA-Seq analysis of colonic mucosa.

Authors:  Juan Bai; Ying Zhu; Ying Dong
Journal:  Genes Genomics       Date:  2018-02-20       Impact factor: 1.839

Review 4.  Recent Advances in Momordica charantia: Functional Components and Biological Activities.

Authors:  Shuo Jia; Mingyue Shen; Fan Zhang; Jianhua Xie
Journal:  Int J Mol Sci       Date:  2017-11-28       Impact factor: 5.923

Review 5.  Adipose Tissue-Specialized Immunologic Features Might Be the Potential Therapeutic Target of Prospective Medicines for Obesity.

Authors:  Fan Yao; Ming Zhang; Li Chen
Journal:  J Diabetes Res       Date:  2017-03-30       Impact factor: 4.011

6.  Anti-Obesity Effect of Bombus ignitus Queen Glycosaminoglycans in Rats on a High-Fat Diet.

Authors:  Mi Young Ahn; Ban Ji Kim; Ha Jeong Kim; Hyung Joo Yoon; Sang Duck Jee; Jae Sam Hwang; Kun-Koo Park
Journal:  Int J Mol Sci       Date:  2017-03-22       Impact factor: 5.923

Review 7.  New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis.

Authors:  Zezheng Gao; Qingwei Li; Xuemin Wu; Xuemin Zhao; Linhua Zhao; Xiaolin Tong
Journal:  J Immunol Res       Date:  2017-10-15       Impact factor: 4.818

8.  Comparative Analysis of Metabolite Profiling of Momordica charantia Leaf and the Anti-Obesity Effect through Regulating Lipid Metabolism.

Authors:  Meiqi Fan; Jae-In Lee; Young-Bae Ryu; Young-Jin Choi; Yujiao Tang; Mirae Oh; Sang-Ho Moon; Bokyung Lee; Eun-Kyung Kim
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

9.  Exploring the inhibitory potentials of Momordica charantia bioactive compounds against Keap1-Kelch protein using computational approaches.

Authors:  Temitope Isaac Adelusi; Misbaudeen Abdul-Hammed; Mukhtar Oluwaseun Idris; Oyedele Qudus Kehinde; Ibrahim Damilare Boyenle; Ukachi Chiamaka Divine; Ibrahim Olaide Adedotun; Ajayi Ayodeji Folorunsho; Oladipo Elijah Kolawole
Journal:  In Silico Pharmacol       Date:  2021-06-25

10.  Bibliometric analysis of research on the role of intestinal microbiota in obesity.

Authors:  Haiqiang Yao; Jin-Yi Wan; Chong-Zhi Wang; Lingru Li; Ji Wang; Yingshuai Li; Wei-Hua Huang; Jinxiang Zeng; Qi Wang; Chun-Su Yuan
Journal:  PeerJ       Date:  2018-06-29       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.